Cellyan Biotechnology Co., Ltd
$0.73
▲
1.59%
2026-04-21 07:18:00
www.9zt.hk
NCM: HKPD
Explore Cellyan Biotechnology Co., Ltd stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$8.03 M
Current Price
$0.73
52W High / Low
$2.76 / $0.37
Stock P/E
—
Book Value
$0.47
Dividend Yield
—
ROCE
3.09%
ROE
-13.38%
Face Value
—
EPS
$-0.06
Exp Qtr EPS
—
Sector
Healthcare
Industry
Pharmaceutical Retailers
Employees
27
Beta
—
Debt / Equity
44.19
Current Ratio
2.93
Quick Ratio
2.8
Forward P/E
—
Price / Sales
0.89
Enterprise Value
$6.63 M
EV / EBITDA
-12.41
EV / Revenue
0.41
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Wellgistics Health, Inc. | $0.13 | — | $17.59 M | — | -11952.35% | 3545.19% | $7.04 / $0.1 | $-0.12 |
| 2. | High Tide Inc. | $2.47 | — | $288.3 M | — | 6.2% | -39.72% | $5.59 / $2.85 | $0.72 |
| 3. | Scienture Holdings, Inc. | $0.42 | — | $16.97 M | 12.89% | -19.95% | -55.65% | $2.6 / $0.24 | $1.73 |
| 4. | Ridgetech, Inc. | $2.21 | 0.16 | $2 M | — | -3.44% | -8.02% | $760.5 / $2.01 | $5.09 |
| 5. | The Procter & Gamble Company | $142.68 | 21.14 | $332.05 B | 3.01% | 22.93% | 31.56% | $171.65 / $137.62 | $22.49 |
| 6. | Meta Platforms, Inc. | $674.43 | 23.33 | $1,711.53 B | 0.31% | 25.69% | 30.24% | $796.25 / $479.8 | $85.87 |
| 7. | The Progressive Corporation | $205.62 | 10.48 | $120.97 B | 0.2% | — | 40.45% | $289.96 / $192.02 | $51.74 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Sales | 20.31 M | 16.69 M | 12.56 M |
| Operating Profit | 0.2 M | 1.67 M | 1.08 M |
| Net Profit | -0.03 M | 1.33 M | 1 M |
| EPS in Rs | -0 | 0.08 | 0.06 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Total Assets | 9.42 M | 8.67 M | 3.41 M |
| Total Liabilities | 4.43 M | 4.41 M | 2.82 M |
| Equity | 4.99 M | 4.25 M | 0.59 M |
| Current Assets | 8.73 M | 7.8 M | 2.75 M |
| Current Liabilities | 2.92 M | 3.18 M | 2.55 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Operating CF | 0.57 M | -0.39 M | 1.73 M |
| Investing CF | -2.45 M | -0.04 M | -0.13 M |
| Financing CF | 2 M | 0.54 M | -1.16 M |
| Free CF | 0.41 M | -0.48 M | 1.61 M |
| Capex | -0.15 M | -0.09 M | -0.12 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue Growth % | 21.72% | 32.91% | — |
| Earnings Growth % | -102.03% | 33.21% | — |
| Profit Margin % | -0.13% | 7.97% | 7.95% |
| Operating Margin % | 0.99% | 10.03% | 8.58% |
| Gross Margin % | 11.89% | 21.32% | 21.81% |
| EBITDA Margin % | 5.94% | 15.19% | 14.01% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.